Clinical Trials
148
Active:12
Completed:51
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:11
Phase 2:36
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (118 trials with phase data)• Click on a phase to view related trials
Not Applicable
59 (50.0%)Phase 2
36 (30.5%)Phase 1
11 (9.3%)Phase 3
10 (8.5%)Early Phase 1
1 (0.8%)Phase 4
1 (0.8%)SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerMetastases
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 40
- Registration Number
- NCT06937281
- Locations
- 🇨🇦
BC Cancer - Vancouver, Vancouver, British Columbia, Canada
DOTATATE PET for Meningioma Radiation Planning
Not Applicable
Not yet recruiting
- Conditions
- Meningioma
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 36
- Registration Number
- NCT06937268
- Locations
- 🇨🇦
BC Cancer - Vancouver, Vancouver, British Columbia, Canada
Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers
Not Applicable
Not yet recruiting
- Conditions
- OligoprogressionOligometastatic DiseaseOligoProgressive Metastatic Disease
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 194
- Registration Number
- NCT06918951
- Locations
- 🇨🇦
BC Cancer - Surrey, Surrey, British Columbia, Canada
Phase II Single Vs Hypofractionated Irradiation for Timely Access to Partial Breast Radiotherapy
Not Applicable
Not yet recruiting
- Conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 60
- Registration Number
- NCT06885671
Time Restricted Eating in Haematological Malignancies
Phase 2
Not yet recruiting
- Conditions
- CancerChronic Lymphocytic Leukemia
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 75
- Registration Number
- NCT06862323
- Locations
- 🇨🇦
BC Cancer, Victoria, British Columbia, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 30
- Next
News
No news found